S
Sidra Rehman
Researcher at COMSATS Institute of Information Technology
Publications - 29
Citations - 826
Sidra Rehman is an academic researcher from COMSATS Institute of Information Technology. The author has contributed to research in topics: Hepatitis C virus & Hepatitis C. The author has an hindex of 11, co-authored 22 publications receiving 580 citations. Previous affiliations of Sidra Rehman include University of the Punjab.
Papers
More filters
Journal ArticleDOI
Oxidative toxicity in diabetes and Alzheimer’s disease: mechanisms behind ROS/ RNS generation
TL;DR: The mechanisms involved in ROS production and their possible association with AD and T2DM pathogenesis and progression are summarized and the role of current treatments that can be linked with reduced oxidative stress and damage is highlighted.
Journal ArticleDOI
An overview of HCV molecular biology, replication and immune responses
TL;DR: Molecular virology, replication and immune responses against HCV are summarized and how HCV escape from adaptive and humoral immune responses are discussed, which will be helpful for development of vaccine againstHCV and discovery of new medicines both from synthetic chemistry and natural sources.
Journal ArticleDOI
In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus
TL;DR: SN extract contains potential antiviral agents against HCV and combination of SN extract with interferon will be better option to treat chronic HCV.
Journal ArticleDOI
Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells
TL;DR: From the above results, it can be concluded that by selecting different molecular targets, specific structure-activity relationship can be achieved by doing mechanistic analysis and additional studies are required for the isolation and recognition of antiviral compound in AN to establish its importance as antiviral drug against HCV.
Journal ArticleDOI
Lysosomotropic agents as HCV entry inhibitors
TL;DR: Results suggest that inhibition of HCV at fusion step by increasing the lysosomal pH will be better option to treat chronic HCV.